Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
NeoProgen, a US-based biotech spinout of University of Maryland, Baltimore, completed a $1.5m seed round on Wednesday backed by the institution’s Maryland Momentum Fund and tech transfer office UM Ventures, as well as University of Maryland, Baltimore and Tedco. NeoProgen is working on a stem cell-based therapy for patients suffering from a heart attack or advanced heart failure. The cells used by the spinout have shown, in preclinical studies, to be significantly more effective in regenerating muscle tissue than comparable…
